课题基金 / 基金详情

Controls of MHC on CD5 B cells in autoimmunity and B-CLL

Controls of MHC on CD5 B cells in autoimmunity and B-CLL
MHC 对自身免疫和 B-CLL 中 CD5 B 细胞的控制
批准号:
02454170
负责人:
SHIRAI Toshikazu
金额:
$4.22万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991

项目摘要

项目成果

SHIRAI Toshikazu的其他基金

相似基金

相关文献

中文摘要
翻译
CD^<5+> B细胞由于参与自身免疫和B细胞型慢性淋巴细胞白血病(B-CLL)而引起了广泛关注。B-CLL是一种最常发生在近亲中的白血病,部分与主要组织相容性复合体(MHC)有关,这是一种与自身免疫性疾病相关的发现。我们建立了MHC(H-2)-同源NZB X NZW(NZB/W)F1小鼠(H-2^<d/z>、H-2^<z/z>和H-2^<d/d>),因为随着动物年龄的增长,只有H-2^<d/z>杂合子发展出与IgG抗DNA抗体相关的严重SLE。这种与年龄相关的变化与脾脏CD^<5+> B细胞的减少同时发生。相比之下,H-2^<z/z>纯合子没有发展成SLE,但反过来,CD^<5+> B细胞的明显克隆性增殖确实发生,类似于B-CLL。H-2^<d/d>纯合子也没有发展成典型的SLE,并且中等的CD 5 ^- B频率持续存在。尽管发现所有三个H-2同源NZB/W F1菌株都产生IgM抗DNA抗体,但只有H-2^<d/z>杂合子产生IgG抗体。主要IgM产生者的表面表型为CD 5 ^+ sIgM^+,而IgG产生者的表面表型为CD 5-sIgM^-。遗传和细胞分析支持了我们的论点,即在杂合子中,IgM到IgG同种型转换可能出现在CD 5 ^+ B细胞中,并且该事件与CD 5分子的丢失有关。由于缺乏分化所需的遗传元件(H-2^<d/Z>),在H-2^<z/z>纯合子中,只有增殖信号在CD 5 ^+ B细胞中起作用。这些观察结果表明,某些不同但相关的MHC单倍型可能易患B-CLL或近亲自身免疫性疾病。
英文摘要
CD^<5+> B cells have attracted much attention, because of their involvement in both autoimmunity and B cell-type chronic lymphocytic leukemia(B-CLL). B-CLL is a type of leukemia most often occuring among close relatives and is partly associated with the major histocompatibility complex(MHC), a finding relevant to autoimmune disease. We established MHC(H-2)-congenic NZB X NZW(NZB/W)Fl mice(H-2^<d/z>, H-2^<z/z>, and H-2^<d/d>), in that only H-2^<d/z> heterozygotes developed severe SLE, associated with IgG anti-DNA antibodies, as the animals aged. Such age-associated changes occurred in parallel with the decrease in the splenic CD^<5+> B cells. By contrast, H-2^<z/z> homozygotes did not develop SLE but, in turn, a marked clonal proliferation of CD^<5+> B cells resembling B-CLL did occur. H-2^<d/d> homozygotes also did not develop the typical SLE, and a moderate CD5^- B frequency persisted. Despite the finding that all the three H-2-congenic NZB/W Fl strains produced IgM anti-DNA antibodies, only the H-2^<d/z> heterozygotes produced IgG antibodies. Whereas the surface phenotype of major IgM producers was CD5^+ sIgM^+, that of IgG producers was CD5-sIgM^-. Genetic and cellular analyses supported our thesis that in the heterozygotes IgM to IgG isotype switching probably emerges in CD5^+ B cells and that this event is associated with the loss of CD5 molecules. Because of the lack of genetic elements (H-2^<d/Z>) required for differentiation, only signals for proliferation would be functioning in CD5^+ B cells in the H-2^<z/z> homozygotes. These observations infer that certain different, but related, MHC haplotypes may predispose either to B-CLL orto autoimmune disease in close relatives.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Okabe,T.,Abe,M.,Takiura,F.,Hirose,S.& Shirai,T.: "Destinct surface phenotypes of B cells responsible for spontaneous production of IgM and IgGーDNA antibodies in autoimmuneーprone NZB X Fl mice." Autoimmunity. 7. 109-120 (1990)
Okabe, T.、Abe, M.、Takiura, F.、Hirose, S. 和 Shirai, T.:“B 细胞的特定表面表型负责在自身免疫倾向的 NZB X Fl 中自发产生 IgM 和 IgG-DNA 抗体7. 109-120(1990)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ogawa,S.,Nishimura,H.,Awaji,M.,Nozawa,S.,Hirose,S. & Shirai,T.: "Nucleotide sequence analysis of MHC class II gene autoimmuneーprone (NZB X NZW)F1 mice." Immunogenetics. 32. 63-67 (1990)
Okawa, S.、Nishimura, H.、Awaji, M.、Nozawa, S.、Hirose, S. 和 Shirai, T.:“MHC II 类基因自身免疫倾向 (NZB X NZW)F1 小鼠的核苷酸序列分析。 “免疫遗传学。32。63-67(1990)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 29 条
    Genetic factors Involved in the Pathogenesis of Autoimmune Disea
    • 批准号:
      11357003
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $15.62万
    • 财政年份:
      1999
    • 负责人:
      SHIRAI Toshikazu
    • 依托单位:
    Genetic polymorphism of SLE
    • 批准号:
      06404024
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $19.84万
    • 财政年份:
      1994
    • 负责人:
      SHIRAI Toshikazu
    • 依托单位:
    Studies of autoimmune disease using mice with genetic recombination
    • 批准号:
      62480144
    • 项目类别:
      Grant-in-Aid for General Scientific Research (B)
    • 资助金额:
      $3.97万
    • 财政年份:
      1987
    • 负责人:
      SHIRAI Toshikazu
    • 依托单位:
    海外基金